European Association for the Study of Diabetes

19/06/2026

🎉 Proud to highlight EASD Early Career Academy committee member Dr. Sini Heinonen (University of Helsinki), who has joined the Metabologia Journal as an associate editor!

📢✍️ Metabologia is open for submissions!

Explore the submission guidelines and share your research: https://metabologia.org/

19/06/2026

🎙️How should continuous glucose monitoring (CGM) be used in people living with type 2 diabetes?

Dame Melanie J Davies DBE and Prof. Amanda Adler discuss the development of a new EASD clinical guideline on CGM in T2D - one of the first guidelines produced under EASD’s new evidence-based guideline programme. The conversation explores why CGM emerged as a priority topic, the importance of patient involvement and the challenges of balancing clinical evidence with real-world implementation.

This new guideline will be presented for the first time at this year's Annual Meeting in Milan: 📅 Wednesday, 30 September 2026 | 🕛 16:30 - 17:30 | 📍 London Hall.

🔗👉 Listen now: https://www.easd.org/media-centre/podcasts/

18/06/2026

Join us in congratulating four long-standing EASD members on receiving prestigious 2026 American Diabetes Association (ADA) National Scientific & Health Care Achievement Awards:

🏆 Chantal Mathieu - Distinguished International Service in the Cause of Diabetes Award
🏆 Naveed Sattar - Outstanding Achievement in Clinical Diabetes Research Award
🏆 Timo Müller - Outstanding Scientific Achievement Award
🏆 Gerald I. Shulman - Albert Renold Award

Their groundbreaking contributions to diabetes research, care, education and mentorship continue to shape the future of diabetes prevention and treatment worldwide.

Congratulations to all awardees on this well-deserved recognition! We look forward to welcoming you to .

17/06/2026

👉🥁Have you missed this year’s ADA Scientific Sessions in New Orleans? EASD e-Learning has got the key scientific highlights for you presented by:

EASD President Prof. Francesco Giorgino, University of Bari Aldo Moro
Prof. Naveed Sattar, University of Glasgow
Prof. Alice Cheng, University of Toronto

🎯 They outline exciting new phase II and phase III trial data on incretin-based therapies and the first release of the updated ADA EASD Consensus Report on the Management of Type 2 Diabetes.

📺 Watch only on the EASD e-Learning platform: https://easd-elearning.eu/news/474/ADA-Scientific-Sessions-2026-Wrap-Up.html

💬 If you attended ADA 2026, what were your scientific highlights? Let us know in the comments.

16/06/2026

🧠 Meet Dr. Ben A. Kappel (Uniklinik RWTH Aachen), grant recipient of the and Sanofi European Diabetes Research Programme in Diabetes associated with Cardiovascular Disease. 👏

In his research project “Network analysis of interactome dysregulation in the pathogenesis of HFpEF in type 2 diabetes”, Dr. Kappel uses paired coronary sinus and arterial sampling combined with integrated proteomics and metabolomics analyses to investigate how type 2 diabetes alters cardiac metabolism and contributes to heart failure with preserved ejection fraction (HFpEF).

The study uncovered convergent signatures of mitochondrial dysfunction, altered substrate handling, and inflammatory lipid signalling, providing new mechanistic insight into HFpEF.

🗣️ “The grant was instrumental in enabling this translational multi-omics project and establishing a unique clinical dataset in HFpEF. It significantly supported my development as an independent investigator and strengthened international collaborations in cardiometabolic research,” Dr. Kappel shares.

📄 Paper currently under preparation for submission
💡 Explore EFSD programmes: https://www.europeandiabetesfoundation.org

15/06/2026

🎉 A huge congratulations to Prof. Melanie Davies on being named a Dame Commander of the Order of the British Empire (DBE) in The King's Birthday Honours List!

Dame Melanie is a long-standing EASD member whose contributions to type 2 diabetes research, policy and care management have had a truly global impact - from pioneering self-management programmes implemented across four continents, to her extraordinary record of more than 130,000 citations. A well-deserved honour. We are proud to count her among our community.

🔗👉 Read more: https://www.leicesterdiabetescentre.org.uk/news-blog/international-diabetes-researcher-becomes-dame

We are delighted to share that our Co-Director, Professor Melanie Davies has been awarded a Dame Commander of the Order of the British Empire (DBE) in the King’s Birthday Honours.

This well-deserved recognition reflects her outstanding contribution to global diabetes, research, policy and care management.

Congratulations from all of us!

Read more: https://www.leicesterdiabetescentre.org.uk/news-blog/international-diabetes-researcher-becomes-dame

15/06/2026

2️⃣days left to submit your Late Breaking Abstracts. To be considered, your abstract must present new information not yet known or fully available at the time of the first submission - no double submissions.

Submit your latest findings before: 📅 17 June 2026 | 🕛 18:00 CEST

Learn more 👉 https://www.easd.org/annual-meeting/easd-2026/scientific-submissions/

🔬 📢 Just 1 week left to submit your Late Breaking Abstracts! The Late Breaking Abstract submission window is still open for truly novel research. New findings with high scientific significance!

Submit your latest findings before: 📅 17 June 2026 | 🕛 18:00 CEST

❗ ❗ Important to note: the late-breaking submission window is not an extension of the April deadline. To be considered, your abstract must present new information not yet known or fully available at the time of the first submission - no double submissions.

For full submission guidelines, visit 👉 https://www.easd.org/annual-meeting/easd-2026/scientific-submissions/

12/06/2026

🪙50 years of attending EASD Annual Meetings: in this special episode, Prof. Eberhard Standl (Helmholtz Munich) reflects on attending his first EASD meeting in 1975, presenting research on diabetic ketoacidosis, and witnessing extraordinary advances in both type 1 and type 2 diabetes over five decades.

From the importance of lifestyle and exercise to the potential reversal of type 2 diabetes, immunotherapies for type 1 diabetes, and emerging links between diabetes and cancer, Prof. Standl shares a unique perspective on where the field has been and where it is heading next.

A fascinating conversation about scientific curiosity, lifelong learning, and the enduring goal of normalising glucose and improving lives.

🎧👉 Listen now: https://www.easd.org/media-centre/podcasts/

11/06/2026

📝 We, European Association for the Study of Diabetes (EASD) and American Diabetes Association (ADA), are inviting public commentary on the 2026 update of the joint Consensus Report on the Management of Type 2 Diabetes.

A symposium was held on 6 June at ADA's 2026 Annual Meeting, where key topics from the updated report were presented. You now have the opportunity to review the slides and share your feedback with the committee before the report is finalised.

📅 The commentary period closes at 11:59 pm ET (17:59 CEST) on 16 June 2026.

View the slides and submit your comments via the link below:
🔗 https://professional.diabetes.org/clinical-support/ada-easd-consensus-statement-management-type-2-diabetes